The FDA Approves a New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
The big news from yesterday is that the Food and Drug Administration (FDA) has approved a MRI-guided, focused ultrasound therapy for the treatment of bone pain associated with metastatic advanced prostate cancer. In a media [...]
HIFU Treatment a Possible Salvage Therapy After Failed EBRT
A recently published article in Urology Times claims that salvage high-intensity focused ultrasound (HIFU) appears to be an effective treatment option for locally recurrent prostate cancer after primary external beam radiation therapy (EBRT) failure. The [...]
Dieing Early Because You Can Not Get Health Insurance – A Possible Future for Americans
I try not to get political in this blog, but current politics are directly involved in our healthcare and that is what I write about in this blog. I write this because all of my [...]
Zytiga (Abiraterone Acetate) Delays Pain Progression in Men with Advanced Prostate Cancer
Data presented at the European Society for Medical Oncology annual congress in Vienna, Austria linked the delay of pain progression the functional decline of men with the newly approved drug Zytiga. The data was derived [...]
New Site from the Early/Expanded Access Committee – Alpharedin Now available at Stanford University (plus 3 other sites)
There was just a new site opened for the early/expanded access program for Alpharedin (Radium-235). The new site is at Stanford University, California. This makes a total of four sites, but most of them have [...]
Understanding Oligometastic Prostate Cancer & Our Ability to Successfully Treat It
It is the general consensus that prostate cancer when still confined to the prostate gland is gland curable, but when it has left the prostate gland and becoming metastatic it is no longer curable. But [...]